TANBYOS Trademark

Trademark Overview

On Friday, November 5, 2021, a trademark application was filed for TANBYOS with the United States Patent and Trademark Office. The USPTO has given the TANBYOS trademark a serial number of 97110021. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, October 31, 2024. This trademark is owned by Tanvex BioPharma, Inc.. The TANBYOS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cancer
tanbyos

General Information

Serial Number97110021
Word MarkTANBYOS
Filing DateFriday, November 5, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, October 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTanvex BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Cayman KYI-1205
KY
Party NameTanvex BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Cayman KYI-1205
KY

Trademark Events

Event DateEvent Description
Tuesday, November 9, 2021NEW APPLICATION ENTERED
Tuesday, November 9, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 17, 2021ASSIGNED TO LIE
Wednesday, November 17, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, January 27, 2022ASSIGNED TO EXAMINER
Friday, January 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 1, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 1, 2022SOU EXTENSION 1 FILED
Tuesday, November 1, 2022SOU EXTENSION 1 GRANTED
Thursday, November 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 17, 2023SOU EXTENSION 2 FILED
Monday, April 17, 2023SOU EXTENSION 2 GRANTED
Wednesday, April 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 2, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 2, 2023SOU EXTENSION 3 FILED
Thursday, November 2, 2023SOU EXTENSION 3 GRANTED
Saturday, November 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 26, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 26, 2024SOU EXTENSION 4 GRANTED
Friday, April 26, 2024SOU EXTENSION 4 FILED
Saturday, April 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2024SOU EXTENSION 5 FILED
Thursday, October 31, 2024SOU EXTENSION 5 GRANTED

Related Keywords

tanbyos cancer treatment preparations pharmaceutical